T2 Biosystems, INC 8-K filings

OTC.Pink

15 Feb 2024

TTOO

8-K: T2 Biosystems Secures $15 Million Debt Conversion, Announces Preliminary 2023 Results and 2024 Revenue Guidance

T2 Biosystems has entered into a securities purchase agreement to convert $15 million of debt into equity, while also reporting preliminary financial results for 2023 and providing revenue guidance for 2024.